Drug intelligence / Profile preview

hydrolyzed walnut leaf extract

Development stage
Preclinical
Modality
Small Molecules
Administration
Topical, Oral
01

Overview

Hydrolyzed walnut leaf extract is a plant-derived preparation obtained by the hydrolysis of leaves from the Juglans regia (walnut) tree. Walnut leaves are rich in bioactive compounds, including phenolic acids (such as caffeoylquinic and p-coumaroylquinic acids), flavonoids (notably quercetin derivatives), alkaloids, saponins, tannins, and juglone—a naphthoquinone compound that is present as a glycoside precursor in fresh leaves and released upon hydrolysis[6][7]. The extract exhibits strong antioxidant activity due to its high content of polyphenols and flavonoids[8]. Pharmacological studies suggest potential anti-inflammatory, antimutagenic, antiproliferative, antimicrobial, hypoglycemic (via inhibition of protein tyrosine phosphatase 1B and enhancement of glucose uptake), lipid-lowering, and skin-conditioning effects[3][4][6][7]. Traditional uses include topical application for burns or skin irritations and oral use for metabolic syndrome-related conditions such as diabetes or dyslipidemia. The mechanism of action is primarily attributed to antioxidant activity—scavenging reactive oxygen/nitrogen species—and modulation of inflammatory pathways; juglone may also contribute via additional mechanisms such as TLR4/NF-κB pathway suppression[3][7].

Other names
hydrolyzed walnut leaf extract
02

Targets

PTPN1 (Protein tyrosine phosphatase 1B)TLR4 (Toll-like receptor 4)

Beyond the preview

Go deeper on hydrolyzed walnut leaf extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hydrolyzed walnut leaf extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call